The risk and severity of specific infections are increased during pregnancy due to a
combination of physiological and immunological changes. Characterizing the maternal …

Recent findings have provided a molecular basis for the combined contributions of
multifaceted risk factors for the onset of multiple sclerosis (MS). MS appears to start as a …

Purpose of review This review presents a comprehensive analysis of the current high-
efficacy disease-modifying therapies (DMTs) available for treatment of multiple sclerosis …

Objective To identify predictors of 10‐year Expanded Disability Status Scale (EDSS) change
after treatment initiation in patients with relapse‐onset multiple sclerosis. Methods Using …

The Canadian Multiple Sclerosis Working Group has updated its treatment optimization
recommendations (TORs) on the optimal use of disease-modifying therapies for patients …

Abstract Purpose of Review We review data available for treatment of multiple sclerosis (MS)
before, during, and after pregnancy. We present recent data on disease-modifying therapies …

Importance Women with multiple sclerosis (MS) experience an elevated risk of relapse after
giving birth. The effect of exclusive breastfeeding on postpartum risk of MS relapse is …

Multiple sclerosis (MS) is the major acquired central nervous system disease of young
adults. It is a female predominant disease. Multiple aspects of MS are influenced by sex …

With evolving diagnostic criteria and the advent of new oral and parenteral therapies for MS,
most current diagnostic and treatment algorithms need revision and updating. The diagnosis …

Objective To determine the rate of relapse occurrence during pregnancy and postpartum.
Methods In a cross-sectional study using the national multiple sclerosis (MS) registry …